EX-10.7 13 d393013dex107.htm EX-10.7 Execution Version PATENT ASSIGNMENT between CARDIFF PROTIDES LIMITED and NUCANA BIOMED LIMITED Dated: 15th March 2012 Ref: [***]Cardiff • May 5th, 2020
Jurisdiction FiledMay 5th, 2020Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended.
PATENT ASSIGNMENT between CARDIFF PROTIDES LIMITED and NUCANA BIOMED LIMITED Dated: 15th March 2012 Ref: [***] Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange...NuCana PLC • September 1st, 2017 • Pharmaceutical preparations • Cardiff
Company FiledSeptember 1st, 2017 Industry JurisdictionPursuant to the Assignment, Licence and Collaboration Agreement (as defined below), the Assignor has agreed to assign to the Assignee, and the Assignee is willing to accept the assignment of the Assignor’s entire right, title and interest in and to the Patents (as defined below) on the terms and conditions set out in this Assignment.
PATENT ASSIGNMENT between CARDIFF PROTIDES LIMITED and NUCANA BIOMED LIMITED Dated: 15th March 2012 Ref: [***] Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange...NuCana BioMed LTD • August 4th, 2017 • Pharmaceutical preparations • Cardiff
Company FiledAugust 4th, 2017 Industry JurisdictionPursuant to the Assignment, Licence and Collaboration Agreement (as defined below), the Assignor has agreed to assign to the Assignee, and the Assignee is willing to accept the assignment of the Assignor’s entire right, title and interest in and to the Patents (as defined below) on the terms and conditions set out in this Assignment.